Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

NCT07324837 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

990

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke, Acute

Interventions

DRUG: non-immunogenic staphylokinase
DRUG: Placebo

Sponsor

Supergene, LLC